New aortic repair device improves patient survival and recovery

Patients who experience a specific type of aortic tear now have a new treatment option available at UI Health Care. The AMDS Hybrid Prosthesis, the world's first aortic arch remodeling device, was recently approved for DeBakey Type 1 aortic dissection patients.

DeBakey Type 1 aortic dissection is a tear in the inner layer of the wall of the aorta—the main artery that carries oxygen-rich blood to the rest of the body. An aortic dissection causes blood to flow between the wall layers, which slows or stops normal blood flow and can lead to a complete rupture of the aorta. The condition is emergent, life-threatening, and requires immediate surgical repair.

The current treatment option involves removing a portion of the damaged aorta and grafting a synthetic tube in its place. These procedures are successful but often fail to treat the remainder of the diseased aorta, which can result in complications and the need for additional procedures in the future.  

The AMDS device is used with the current treatment and allows for a minimally invasive option, instead of another open-heart procedure, if future interventions are needed.

The new AMDS device strengthens and stabilizes the aorta, preserves the aorta’s natural arch, improves blood flow, and reduces the risk of, stroke, kidney failure, heart attack, and death.